Kyverna Therapeutics, Inc. Contracts & Agreements

24 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Letter Agreement, dated November 20, 2024, between Kyverna Therapeutics, Inc. and James Chung, M.D., Ph.D
Kyverna Therapeutics, Inc.
2024
Kyverna Therapeutics, Inc. 2024 Inducement Equity Incentive Plan
Bonus & Incentive Agreements
Kyverna Therapeutics, Inc.
2024
Separation and General Release Agreement, dated September 13, 2024, between Kyverna Therapeutics, Inc. and Peter Maag, Ph.D
Separation Agreements
Kyverna Therapeutics, Inc.
2024
Employment Offer Letter, dated September 14, 2024, between Kyverna Therapeutics, Inc. and Warner Biddle
Employment Agreements
Kyverna Therapeutics, Inc.
2024
Description of Registrants Securities
Kyverna Therapeutics, Inc.
2024
Kyverna Therapeutics, Inc. 2024 Equity Incentive Plan Form of Restricted Stock Unit Award Agreement
Bonus & Incentive Agreements
Kyverna Therapeutics, Inc.
2024
Kyverna Therapeutics, Inc. 2024 Equity Incentive Plan
Bonus & Incentive Agreements
Kyverna Therapeutics, Inc.
2024
Kyverna Therapeutics, Inc. Non-Employee Director Compensation Program
Compensation Agreements
Kyverna Therapeutics, Inc.
2024
Form of Indemnification Agreement
Indemnification Agreements
Kyverna Therapeutics, Inc.
2024
Kyverna Therapeutics, Inc. 2024 Employee Stock Purchase Plan
Stock Agreements
Kyverna Therapeutics, Inc.
2024
Kyverna Therapeutics, Inc. 2024 Equity Incentive Plan Form of Restricted Stock Unit Award Agreement
Bonus & Incentive Agreements
Kyverna Therapeutics, Inc.
2024
Kyverna Therapeutics, Inc. 2024 Equity Incentive Plan Form of Stock Option Agreement
Bonus & Incentive Agreements
Kyverna Therapeutics, Inc.
2024
Form of Underwriting Agreement
Underwriting Agreements
Kyverna Therapeutics, Inc.
2024
Form of Common Stock Certificate
Stock Agreements
Kyverna Therapeutics, Inc.
2024
Patent License Agreement (License Number L-159-2021-0), dated May 27, 2021, between Kyverna Therapeutics, Inc. and the National Institutes of Health
License Agreements
Kyverna Therapeutics, Inc.
2024
Patent License Agreement (License Number L-158-2021-0), dated May 20, 2021, between Kyverna Therapeutics, Inc. and the National Institutes of Health
License Agreements
Kyverna Therapeutics, Inc.
2024
License and Collaboration Agreement, dated December 29, 2021, between Kyverna Therapeutics, Inc. and Intellia Therapeutics, Inc
Collaboration Agreements
Kyverna Therapeutics, Inc.
2024
First Amendment to Office/Laboratory Lease, dated November 29, 2021, between Kyverna Therapeutics, Inc. and Emery Station Office II, LLC
Lease Agreements
Kyverna Therapeutics, Inc.
2024
Office/Laboratory Lease, dated July 21, 2020, between Kyverna Therapeutics, Inc. and Emery Station Office II, LLC
Lease Agreements
Kyverna Therapeutics, Inc.
2024
Amended and Restated Investors Rights Agreement, dated November 9, 2021
Investor Rights Agreements
Kyverna Therapeutics, Inc.
2024
Employment Offer Letter, dated July 9, 2021, between Kyverna Therapeutics, Inc. and Karen Walker
Employment Agreements
Kyverna Therapeutics, Inc.
2024
Employment Offer Letter, dated March 23, 2021, between Kyverna Therapeutics, Inc. and James Chung, M.D., Ph.D
Employment Agreements
Kyverna Therapeutics, Inc.
2024
Employment Offer Letter, dated October 4, 2022, between Kyverna Therapeutics, Inc. and Peter Maag, Ph.D
Employment Agreements
Kyverna Therapeutics, Inc.
2024
Kyverna Therapeutics, Inc. Amended and Restated 2019 Stock Plan, as amended, and forms of agreement thereunder
Stock Agreements
Kyverna Therapeutics, Inc.
2024